Teleflex Inc is a provider of medical technology products focused on enhancing clinical benefits, improving patient and provider safety and reducing total procedural costs... Show more
a provider of medical devices for critical care, urology and surgery
Industry PharmaceuticalsOther
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| COIG | 5.78 | 0.16 | +2.94% |
| Leverage Shares 2X Long COIN Daily ETF (COIG) | |||
| MAMB | 23.03 | 0.06 | +0.25% |
| Monarch Ambassador Income Index ETF (MAMB) | |||
| TCAF | 42.28 | 0.01 | +0.02% |
| T. Rowe Price Capital Appreciation Equity ETF (TCAF) | |||
| HTAX | 23.00 | N/A | N/A |
| Macquarie National High-Yield Municipal Bond ETF | |||
| SEEM | 38.74 | -0.04 | -0.10% |
| SEI Select Emerging Markets Equity ETF (SEEM) | |||
A.I.dvisor indicates that over the last year, TFX has been loosely correlated with A. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if TFX jumps, then A could also see price increases.
| Ticker / NAME | Correlation To TFX | 1D Price Change % | ||
|---|---|---|---|---|
| TFX | 100% | +0.86% | ||
| A - TFX | 51% Loosely correlated | -3.27% | ||
| RVTY - TFX | 47% Loosely correlated | -2.51% | ||
| TNDM - TFX | 44% Loosely correlated | +1.16% | ||
| SNN - TFX | 42% Loosely correlated | -1.41% | ||
| MTD - TFX | 42% Loosely correlated | -1.97% | ||
More | ||||
| Ticker / NAME | Correlation To TFX | 1D Price Change % |
|---|---|---|
| TFX | 100% | +0.86% |
| Pharmaceuticals category (154 stocks) | 30% Poorly correlated | -0.74% |
| Pharmaceuticals: Other category (50 stocks) | 26% Poorly correlated | -0.52% |
Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where TFX declined for three days, in 229 of 322 cases, the price declined further within the following month. The odds of a continued downward trend are 71%.
TFX moved below its 50-day moving average on September 10, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for TFX crossed bearishly below the 50-day moving average on September 16, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 7 of 16 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 44%.
The Aroon Indicator for TFX entered a downward trend on October 01, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where TFX's RSI Oscillator exited the oversold zone, 26 of 41 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 63%.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 31 of 63 cases where TFX's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 49%.
The Momentum Indicator moved above the 0 level on October 01, 2026. You may want to consider a long position or call options on TFX as a result. In 48 of 85 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 56%.
The Moving Average Convergence Divergence (MACD) for TFX just turned positive on October 01, 2026. Looking at past instances where TFX's MACD turned positive, the stock continued to rise in 28 of 54 cases over the following month. The odds of a continued upward trend are 52%.
Following a +6.07% 3-day Advance, the price is estimated to grow further. Considering data from situations where TFX advanced for three days, in 166 of 287 cases, the price rose further within the following month. The odds of a continued upward trend are 58%.
TFX may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Tickeron PE Growth Rating for this company is 1 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 58 (best 1 - 100 worst), indicating fairly steady price growth. TFX’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 91 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.858) is normal, around the industry mean (5.011). TFX's P/E Ratio (2279.670) is considerably higher than the industry average of (163.451). Projected Growth (PEG Ratio) (0.165) is also within normal values, averaging (4.456). Dividend Yield (0.011) settles around the average of (0.005) among similar stocks. P/S Ratio (2.508) is also within normal values, averaging (56.074).
The Tickeron SMR rating for this company is 97 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. TFX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 96, placing this stock worse than average.